Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Historical Portfolio Holders from Q2 2018 to Q2 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM STK CL A
Shares, excl. options Q1 2024
107 M
Holdings value Q1 2024
$649 M
Value change Q1 2024
-$9.43 M
Grand Portfolio weight change Q1 2024
0%
Number of holders
169
Number of buys Q1 2024
94
Number of sells Q1 2024
-52
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.002%
CUSIP
03168L105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 64 $406 +$228 $6.34 1
2024 Q1 107 M $649 M -$9.43 M $6.06 169
2023 Q4 109 M $663 M +$52.6 M $6.07 150
2023 Q3 102 M $430 M +$19.8 M $4.22 142
2023 Q2 97.4 M $302 M +$3.37 M $3.10 123
2023 Q1 96.6 M $134 M -$8.16 M $1.39 141
2022 Q4 102 M $203 M -$3.61 M $1.99 153
2022 Q3 92 M $186 M -$782 K $2.02 142
2022 Q2 99.2 M $315 M -$3.52 M $3.18 139
2022 Q1 92.5 M $385 M -$3.04 M $4.17 151
2021 Q4 101 M $480 M -$738 K $4.79 147
2021 Q3 100 M $535 M +$2.64 M $5.34 147
2021 Q2 99.5 M $509 M -$13.5 M $5.12 152
2021 Q1 101 M $683 M +$24.4 M $6.73 153
2020 Q4 99.4 M $454 M -$9.09 M $4.57 127
2020 Q3 101 M $394 M -$1.17 M $3.88 132
2020 Q2 101 M $480 M +$13.7 M $4.76 131
2020 Q1 98.2 M $342 M -$17.3 M $3.48 113
2019 Q4 101 M $487 M -$9.63 M $4.82 115
2019 Q3 108 M $314 M +$20.5 M $2.90 107
2019 Q2 95.2 M $683 M -$110 M $7.17 115
2019 Q1 109 M $1.54 B -$98.8 M $14.17 152
2018 Q4 116 M $1.57 B +$89.7 M $13.53 157
2018 Q3 108 M $2.41 B +$283 M $22.19 164
2018 Q2 97.4 M $1.6 B +$1.6 B $16.41 161